Cargando…

Should C-reactive protein concentration at ICU discharge be used as a prognostic marker?

BACKGROUND: About one third of hospital mortality in critically ill patients occurs after Intensive Care Unit (ICU) discharge. Some authors have recently hypothesized that unresolved or latent inflammation and sepsis may be an important factor that contributes to death following successful discharge...

Descripción completa

Detalles Bibliográficos
Autores principales: Silvestre, Joana, Coelho, Luís, Póvoa, Pedro
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954920/
https://www.ncbi.nlm.nih.gov/pubmed/20875120
http://dx.doi.org/10.1186/1471-2253-10-17
_version_ 1782187977484533760
author Silvestre, Joana
Coelho, Luís
Póvoa, Pedro
author_facet Silvestre, Joana
Coelho, Luís
Póvoa, Pedro
author_sort Silvestre, Joana
collection PubMed
description BACKGROUND: About one third of hospital mortality in critically ill patients occurs after Intensive Care Unit (ICU) discharge. Some authors have recently hypothesized that unresolved or latent inflammation and sepsis may be an important factor that contributes to death following successful discharge from the ICU. AIM: The aim of our study was to determine the ability of the clinical and inflammatory markers at ICU discharge to predict post-ICU mortality. METHODS: A prospective observational cohort study was conducted during a 14-month period in an 8 bed polyvalent ICU. Acute Physiology and Chronic Health Evaluation (APACHE) II score, Simplified Acute Physiology Score (SAPS) II, Sequential Organ Failure Assessment (SOFA) score, Therapeutic Intervention Scoring System-28 (TISS-28), C-reactive protein (CRP), white cell count (WCC) and body temperature of the day of ICU discharge were collected from patients who survived their first ICU admission. RESULTS: During this period 156 patients were discharged alive from the ICU. A total of 29 patients (18.6%) died after ICU discharge. There were no differences in clinical and demographic characteristics between survivors and nonsurvivors. C-reactive protein levels at ICU discharge were not significantly different between survivors and nonsurvivors. The area under receiver operating characteristics curves of APACHE II, SAPS II, SOFA, TISS-28, CRP, WCC and body temperature at ICU discharge as prognostic markers of hospital death were 0.76 (95% confidence interval (CI) 0.67-0.86); 0.75 (95% CI 0.66-0.85); 0.72 (95% CI 0.62-0.83); 0.64 (95% CI 0.52-0.77); 0.55 (95% CI 0.43-0.67); 0.55 (95% CI 0.42-0.66) and 0.54 (95% CI 0.44-0.67) respectively. The hospital mortality rate of the patients with CRP <5, 5-10, >10 mg/dL was 15.1%, 16.1% and 33.3% respectively (p = NS). CONCLUSIONS: At ICU discharge serum CRP concentration was a poor marker of post-ICU prognosis. Post-ICU death appears to be unrelated to the persistent inflammatory response.
format Text
id pubmed-2954920
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29549202010-10-15 Should C-reactive protein concentration at ICU discharge be used as a prognostic marker? Silvestre, Joana Coelho, Luís Póvoa, Pedro BMC Anesthesiol Research Article BACKGROUND: About one third of hospital mortality in critically ill patients occurs after Intensive Care Unit (ICU) discharge. Some authors have recently hypothesized that unresolved or latent inflammation and sepsis may be an important factor that contributes to death following successful discharge from the ICU. AIM: The aim of our study was to determine the ability of the clinical and inflammatory markers at ICU discharge to predict post-ICU mortality. METHODS: A prospective observational cohort study was conducted during a 14-month period in an 8 bed polyvalent ICU. Acute Physiology and Chronic Health Evaluation (APACHE) II score, Simplified Acute Physiology Score (SAPS) II, Sequential Organ Failure Assessment (SOFA) score, Therapeutic Intervention Scoring System-28 (TISS-28), C-reactive protein (CRP), white cell count (WCC) and body temperature of the day of ICU discharge were collected from patients who survived their first ICU admission. RESULTS: During this period 156 patients were discharged alive from the ICU. A total of 29 patients (18.6%) died after ICU discharge. There were no differences in clinical and demographic characteristics between survivors and nonsurvivors. C-reactive protein levels at ICU discharge were not significantly different between survivors and nonsurvivors. The area under receiver operating characteristics curves of APACHE II, SAPS II, SOFA, TISS-28, CRP, WCC and body temperature at ICU discharge as prognostic markers of hospital death were 0.76 (95% confidence interval (CI) 0.67-0.86); 0.75 (95% CI 0.66-0.85); 0.72 (95% CI 0.62-0.83); 0.64 (95% CI 0.52-0.77); 0.55 (95% CI 0.43-0.67); 0.55 (95% CI 0.42-0.66) and 0.54 (95% CI 0.44-0.67) respectively. The hospital mortality rate of the patients with CRP <5, 5-10, >10 mg/dL was 15.1%, 16.1% and 33.3% respectively (p = NS). CONCLUSIONS: At ICU discharge serum CRP concentration was a poor marker of post-ICU prognosis. Post-ICU death appears to be unrelated to the persistent inflammatory response. BioMed Central 2010-09-27 /pmc/articles/PMC2954920/ /pubmed/20875120 http://dx.doi.org/10.1186/1471-2253-10-17 Text en Copyright ©2010 Silvestre et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Silvestre, Joana
Coelho, Luís
Póvoa, Pedro
Should C-reactive protein concentration at ICU discharge be used as a prognostic marker?
title Should C-reactive protein concentration at ICU discharge be used as a prognostic marker?
title_full Should C-reactive protein concentration at ICU discharge be used as a prognostic marker?
title_fullStr Should C-reactive protein concentration at ICU discharge be used as a prognostic marker?
title_full_unstemmed Should C-reactive protein concentration at ICU discharge be used as a prognostic marker?
title_short Should C-reactive protein concentration at ICU discharge be used as a prognostic marker?
title_sort should c-reactive protein concentration at icu discharge be used as a prognostic marker?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954920/
https://www.ncbi.nlm.nih.gov/pubmed/20875120
http://dx.doi.org/10.1186/1471-2253-10-17
work_keys_str_mv AT silvestrejoana shouldcreactiveproteinconcentrationaticudischargebeusedasaprognosticmarker
AT coelholuis shouldcreactiveproteinconcentrationaticudischargebeusedasaprognosticmarker
AT povoapedro shouldcreactiveproteinconcentrationaticudischargebeusedasaprognosticmarker